Akoya Biosciences, Inc.
NASDAQ: AKYA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Brian McKelligon
- Employees
- 205
- Headquarters
- Marlborough, United States
- IPO year
- 2021
- Market cap
- $64.4M
- Website
- https://www.akoyabio.com
Loading AKYA…
Loading profile data…Frequently asked questions about AKYA
What does Akoya Biosciences, Inc. (AKYA) do?
Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product line...
Where does AKYA trade?
Akoya Biosciences, Inc. (AKYA) trades on the NASDAQ Global Select.
What sector is AKYA in?
Akoya Biosciences, Inc. (AKYA) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Akoya Biosciences, Inc.?
Brian McKelligon is the chief executive officer of Akoya Biosciences, Inc. (AKYA).
Where is Akoya Biosciences, Inc. headquartered?
Akoya Biosciences, Inc. is headquartered in United States.
Does AKYA pay a dividend?
Akoya Biosciences, Inc. (AKYA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AKYA go public?
Akoya Biosciences, Inc. (AKYA) completed its initial public offering in 2021.